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Summary
Intracellular signaling from the T cell receptor (TCR)'/CD3 complex is likely to be mediated
by associated protein tyrosine kinases such as p59fyn(T), ZAP-70, and the CD4:p56Ick and
CD8:p56Ick coreceptors. The nature of the signaling cascade initiated by these kinases, their
specificities, and downstream targets remain to be elucidated. The TCR-r/CD3:p59fyniTl
complex has previously been noted to coprecipitate a 120/130-kD doublet (p120/130). This
intracellular protein of unknown identity associates directly with p5gfyn(T) within the receptor
complex. In this study, we have shown that this interaction with p120/130 is specifically mediated
by the SH2 domain (not thefyn-SH3 domain) of p59fyn(T). Further, based on the results of in
vitro kinase assays, p120/130 appears to be preferentially associated with p59fy"(T) in T cells, and
not with p56ick. Antibody reprecipitation studies identified p120/130 as a previously described
130-kD substrate of pp60°-S- whose function and structure is unknown. TCR-r/CD3 induced
activation of T cells augmented the tyrosine phosphorylation of p120/130 in vivo as detected
by antibody and GST.fyn-SH2 fusion proteins. p120/130 represents the first identified
p59fy"1T>:SH2 binding substrate in T cells, and as such is likely to play a key role in the early
events of T cell activation.
Engagement of the antigen-receptor complex (TCR-~/
CD3) of T lymphocytes triggers a tyrosine phosphory-
lation cascade that is crucial to the activation process (1).
Various candidate protein tyrosine kinases including three
members of the src family of protein tyrosine kinases, p561°k,
P59fyn(T), and p60ye, (2), and related kinases such as ZAP-70
(3) and p72t,k (4) are expressed in T cells. p561°k can associate
with the cytoplasmic tails of CD4 and CD8 (5, 6; for review
see Rudd et al. [2]). In turn, CD4:p56I°k complexes can as-
sociate with the TCR-~/CD3 complex (7). p56uk expression
has been found crucial to TCR-r/CD3 mediated T cell acti-
vation (8, 9). By contrast, p59fY" can be expressed by mutu-
ally exclusive splicing as two isoforms, a unique form
(p59fy"(T)) being expressed in T cells (10). p59fyn(T) is as-
sociated with the CD3 y,S,e, chains and the TCR-rsubunits
ofthe TCR-~/CD3 complex (11), whereas ZAP-70 associates
selectively with the ~ chain (12). p5gfyn(T) associates consti-
tutively with the TCR-r/CD3 complex (13), whereas ZAP-
70 associates after ligation of the complex (12) . Engagement
of the TCR-~/CD3 complex with anti-CD3 Abs stimulates
the activity of p59fyn(T) (14, 15) . Overexpression of p5gfyn(T)
in transgenic mice acts to potentiate T cell proliferation,
whereas the absence of the kinase causes partial defects in
signaling (16-18).
A major challenge in understanding the mechanism by
which these receptor-associated protein tyrosine kinases ini-
tiate T cell proliferation will be to define the downstream
targets of an intracellular cascade. In this context, it is im-
portant to note that src-related kinases such as p59fy"(T) are
comprised ofsrc-homology 2 and 3 domains (SH2 and SH3)
with the potential to bind to intracellular substrates (2). In-
tracellular proteins with enzymatic activities such as phos-
pholipase Cy (PLCy),t the p85 subunit of PI-3 kinase and
rasGTP'ase activating protein (rasGAP) carry related SH2 do-
mains (19). SH2 domains can also be expressed within smaller
noncatalytic adaptor proteins such as NCK and SHC (20,
21) . Both catalytic and noncatalytic SH2-carrying proteins
bind to tyrosine phosphorylated residues within the cyto-
plasmic regions of the receptor tyrosine kinases such as the
platelet-derived growth factor (PDGF), epidermal growth
factor (EGF), and CSF-1 receptors (22, 23). By comparison,
the smaller SH3 domains bind proline-rich motifs first defined
in the 3BP-1 protein (24, 25). Related motifs have been found
in a variety of intracellular proteins such as formin and the
m4 muscarinic acetylcholine receptor (25). Deletion of SH2
or SH3 domains results in defective T cell signals (26, 27).
Thus, the SH2 and SH3 domains of p59fyn(T) are likely to
be important mediators in the interaction ofthe TCR-~/CD3
complex with downstream messengers.
I Abbreviations used in this paper. GST, Glutathione S-Transferase; PDGF,
platelet-derived growth factor; PLCy, phospholipase Cy.
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complexinduced thedramatic phosphorylation of ap120/130
polypeptide associated with p59fy°(T) and the TCR-r/CD3
complex (14) . In this study, we demonstrate that p120/130
associates specifically with thefyn-SH2 domain (and not the
fyn-SH3 domain) and corresponds to a previously identified
p130 protein found associated with v-src in transfected chicken
fibroblasts (28) . However, in vitro kinase data suggestedthat
in T cells, p120/130 is found preferentially associated with
p59f yn(T), but not p56)ck . This introduces the possibility that
p120/130may serve as a marker for signals generated by the
fyn kinase in response to antigen stimulation of theTCR-~/
CD3 complex .
Materials and Methods
Cell Lines and Antibodies.
￿
The DC27.10 murine T cell hy-
bridoma (29) was grown in RPMI supplemented with 5% FCS,
1% penicillin and Streptomycin, and 1% L-glutamine. Abs used
include the hamster anti-murineCD3e chainmAb 145-2C11 (gift
ofJ. Bluestone, University ofChicago, Chicago, IL) (30), a rabbit
anti-fyn antisera raised against a synthetic peptide containingresidues
35-51 of the N1-12-terminal region of p59fY1, the mouse anti-
chicken p130 mAb 4F4 (IgM) (28), and the mouse anti-
phosphotyrosine mAb 4G10 (gift of Drs . B. Druker andT Roberts,
Dana-Farber Cancer Institute) (31) .
TCR-r/CD3 Stimulation, In Vitro Kinase Assays, and Immunoblot-
ting . Cross-linking of the TCR-~/CD3complex, in vitro kinase
assays, andimmunoblotting were carried out as previouslydescribed
(14) . For reprecipitation analysis, bands containing the specific phos-
pholabeled proteins were excised from SDS-PAGE gels, the pro-
teins were eluted for 8-12 h in 50 mM ammonium bicarbonate,
0.1% SDS, concentrated with Centricon filters (Amicon, Beverly,
MA), and diluted to 1 ml oflysis buffer before immunoprecipita-
tion with the Abs . The immunoprecipitates were then analyzed
by SDS-PAGE and autoradiography.
GSTfyn Fusion Proteins.
￿
SH2 (residues 149-257), SH3 (82-148),
and SH2/SH3 (82-257) encoding sequences from a cDNA clone
for the mouseT cell-specific isoform of p59'n (10) were subcloned
into the pGEX-2T expression vector plasmid (Pharmacia, Uppsala,
Sweden) and the resulting fusion proteins were purified andused
in precipitations from cell lysates as previously described (32) .
Results
In an attempt to identify a marker for signals specifically
generated by TCR-~/CD3-associated p59fyn(T), we have at-
tempted to identify TCR-~/CD3 and p59f~n(T) associated
downstream substrates . As shownin Fig . 1, anti-CD3 precipi-
tates derived from cell lysates from the mouse hybridoma
DC27.10 and labeled in an in vitro kinase assay showed two
heavily labeled sets ofbands at 72kD (p72) and 120/130 kD
(p120/130) in addition to more faintly labeled bands corre-
sponding to p59fynm and the TCR-~/CD3 subunits (lane 2) .
Anti-fyn serum precipitated a heavily labeled band at 59 kD
corresponding to p59fy° (T), as well as the p120/130 doublet
(lanes 3-5) . A faint amount of a 72-kD band was also visual-
ized,but significantly less intenselythan seen in the anti-CD3
precipitates . This anti-fyn and a portion of theCD3-associated
p72 band corresponds to a serine/threonine phosphorylated
Figure 1.
￿
Engagement of TCR-~/CD3 complex stimulates detection of p59fy-(T) associated p120/130. Lysates from DC27.10 cells were prepared
using 1% Brij 96 lysis buffer, immunoprecipitated with the indicated Abs and the immune complexes subjected to a Knase assay. (Lane 1) Rabbit
preimmune serum ; (lanes 2 and 9-14) anti-CD3 ; (lane 3) anti-fyn rabbit antisera ; (lane 4) anti-fyn mouse monoclonal 33B1 ; (lane S) CST1 ; (lanes
6-8) three independently generated anti-Ick rabbit antisera raised against the unique NHZ-terminal domain . (Lanes 9-14) Intact cells were incubated
at 37°C with anti-CD3 Ab to cross-link theTCR-~/CD3 complex for the indicated times (minutes) before lysis . Time 0 actually corresponds to an
incubation with the rabbit anti-hamster Ab alone for 10 min at 37°C . The labeled samples were then separated by 10% SIDS-PAGE, treated with
1 M KOH for 1 h at 56°C to preferentially remove serine/threonine labeling, and exposed to autoradiography. The right panel is a phosphoamino
acid analysis of the CD3 associated p120/130, purified from a phospholabeled anti-CD3 precipitate and excised from a gel not treated with KOH.
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correspond to ZAP-70 (3) . Significantly, two other anti-fyn
Abs, 33B1 (lane 4), a fyn-specific mouse mAb against the
fyn-SH3 domain Ganssen,O., and C . E. Rudd, unpublished
results) andCST-1(lane 5), a pan-reactive rabbit antisera raised
against a COOH-terminus of pp60-- and which cross-
reacts with p60y- and p59fyn (34), also precipitated a similar
pattern of phosphoproteins. In contrast, repeated experiments
using a panel of anti-lck antisera (lanes 6-8) failed to precipi-
tate detectable amounts of p120/130, indicating that p120/130
may preferentially associate with p59f"'(T) (lanes 3-5) . Ab-
mediated cross-linking of theTCRr/CD3 complex followed
by an in vitro kinase assay of the anti-CD3 complexes purified
from cell lysates showed the rapid phosphorylation ofp120/130
(lanes 9-14) . More faintly labeled p59f'°(T), CD3, and TCR
chains were also visualized. Similar results were obtained
with the human Jurkat T cell line and purified T cells ([14]
and data not shown) . Phosphopeptide map analysis of the
p120 and p130 bands revealed that they were the same mole-
cule (data not shown) . Phosphoamino acid analysis revealed
that p120/130 was phosphorylated in tyrosine residues (Fig.
1, right) .
We were next interested in determining the region within
p59fy"(T) to which p120/130 bound . Given the high degree
of tyrosine phosphorylation of p120/130 and that the SH2
domains bind to various phosphotyrosine residues (35), the
p59fyn(T)-SH2 domain was of particular interest . Glutathione
S-Transferase (GST) fusion proteins were constructed with
fyn-SH2, fyn-SH3, orfyn-SH2/SH3 domains and were then
used in precipitation experiments. p120/130 derived from in
vitro-labeled anti-fj n precipitates were efficiently and equally
recognized by thefyn-SH2 and thefyn-SH2/SH3 fusion pro-
teins (Fig. 2 A, lanes 3 and 5, respectively), but not by the
fyn-SH3 domain (lane 4) or GST alone (lane 2) . Identical
results were obtained using p120/130 from anti-fyn precipi-
tates from human T cells (data not shown) . Anti-CD3-
associated p120/130 was also recognized by thefyn-SH2 fu-
sion protein (Fig . 2 A, lane 8) .
To further establish the interaction of the SH2 domain of
p59f'n(T) with p120/130 as purified from freshly isolated ly-
sates (without in vitro labeling), we carried out antiphospho-
tyrosine immunoblotting of fyn-SH2, fyn-SH3, and fyn-
SH2/SH3 precipitates from total cell lysates (Fig . 2 B, lanes
2-5) . The fyn-SH2 domain precipitated a series of at least
10 polypeptides labeled on tyrosine residues (lane 3) . By con-
trast, thefyn-SH3 domain precipitated a distinct set of some
four polypeptides (lane 4), whereas the combination offyn-
SH2/SH3 proteins precipitated both sets of proteins (lane 5) .
The p120/130 doublet was a prominent protein precipitated
by the fyn-SH2 domain (lanes 3 and 5) .
In v-src transfected chicken embryo fibroblasts, several pro-
teins have been identified that act as substrates for the acti-
vated form of pp60-1c (28) . To determine whether p120/130
was related to any of these proteins, reprecipitation analysis
Figure 2 .
￿
The SH2 domain of p59fynM mediates binding of p120/130 to the TCR-j-/CD3 complex . (A) Reprecipitation analysis ofin vitro labeled
p120/130 . Phospholabeled anti-fyn (lanes 1-5) orCD3 (lanes 6-8) associated p120/130 material was eluted from polyacrylamide gels and equal aliquots
subjected to precipitation with Glutathione STransferase (GST) fusion proteins expressing the SH2 and/or SH3 domains of fyn. Lanes 1 and 6 are
control aliquots of the gel purified protein before reprecipitation. (B) Anti-phosphotyrosine immunoblotting. Lysates from 50 x 106 DC27.10 cells
were prepared with 1% NP-40 lysis buffer and incubated with anti-fyn (lane 1) and GST fusion proteins (lanes 2-5) .
2109
￿
da Silva et al .was conducted on 32p-labeled p120/130 eluted from SDS-
PAGE . As shown in Fig. 3A, the p120/130 was directly rec-
ognized by a mAb (termed 4F4) raised against the p130 mol-
ecule (lane 5), but not by 21312 (against a distinct p120) (lane
3) or by 2A7 (anti-p125fak) (lane 4) . The specificity of this
recognition was further established by the failure of two
isotype-matched (IgM) control Abs, anti-CD6 (lane 6), and
anti-class I (lane 7), to recognize purified p120/130 . Similar
results were obtained with anti-CD3-associated material (lanes
8-10) . Identical results were also obtained from fyn-associated
p120/130 material purified from human T lymphocytes and
Jurkat cells (data not shown) . The 4F4 Ab also recognized
the SH2-n-associated p120/130 from cell lysates (Fig . 3 B,
lane 5) . Similarly, antiphosphotyrosine Abs andGSTfyn-SH2
domains precipitated the protein (lanes 8 and 7, respectively) .
The negative controls GST and RaM failed to precipitate ma-
terial (lanes 6 and 4, respectively) . In a reciprocal experiment,
p120/130 material immunoprecipitated by the 4F4 Ab could
be reprecipitated by the SH2fyn but not by SH3-yn (data
not shown) .
Having established p120/130 as a phosphotyrosine con-
taining SH2 binding protein, we next attempted to deter-
mine whether there was an increase infyn-SH2 recognition
ofthe phosphotyrosine labeled p120/130 due to TCR-~/CD3
ligation . As shown in Fig. 3 C, anti-CD3 stimulation in-
duced an increase in the levels of tyrosine phosphorylation
ofp120/130 as detected by antiphosphotyrosine immunoblot-
2110
ting against whole cell lysates (lanes 1 and 2) and in precipi-
tates with anti-CD3 (lanes 3 and 4), anti-fyn (lanes 5 and
6), and anti-p130 (lanes 7 and 8) . Significantly, MR-t/CD3
stimulation also resulted in increased detection of tyrosine
phosphorylated p120/130 inSH2-yn precipitates (lanes 9 and
10) . These observations are consistent with the results ob-
tained with the in vitro labeled p120/130 (Fig. 1) . Whether
increased detection oftyrosine phosphorylated p120/130 results
from increased recruitment to the TCR-r/CD3 :p59fyn(T)
complex and/or increased phosphorylation of pre-bound
p120/130 remains to be determined .
Discussion
In this study, we have defined apotential downstream target
bound to p59fm(T) and the associated TCR-~/CD3 complex .
We had previously shown that p120/130 associates directly
with p59fyn in fibroblasts (14) . In this study, we have
mapped the site ofp120/130 binding to the SH2 domain of
p59fyn(T) . p59fyn(T) is therefore organized into functionally
discrete motifs that can mediate binding to both its receptor
and downstream intracellular proteins . p59fyn(T) associates
with the TCR ~ and CD3 y, 6, and e chains via its NH2-
terminal 10 amino acids (11) and to the phosphatidylinositol
(PI) 3-kinase via its SH3 domain (32) . The Fyn-SH2 domain
is still available to bind and recruit p120/130. This was demon-
strated by the fact that receptor-bound p59fm(T) is capable of
TCR-r/CD3-p59fr-Associated p120/130 Binds to fyn-SH2 Domain
Figure 3 .
￿
p120/130 corresponds to a v-src substrate
from chicken fibroblasts and is tyrosine phosphorylated
in response to TCR-~/CD3 ligation . (A) Reprecipita-
tion analysis of in vitro labeled p120/130 . Phosphola-
beledanti-fyn (lanes 1-7) orCD3 (lanes 8-10) associated
p120/130 material was eluted from polyacrylamide gels
and equal aliquots subjected to precipitation with rabbit
anti-mouse (lanes 2 and 9), anti-p120 (lane 3), anti-
p125f1 k (lane 4), anti-p130 (lanes 5 and 10), anti-CD6
(lane 6), and anti-class I (lane 7) . Lanes 1 and 8 are con-
trol aliquots ofthe gel-purified proteinbefore reprecipi-
tation . (B) Anti-p130 recognition of SH2-associated
p120/130 . Cell lysates were precipitated with anti-fyn
(lane 1) or GSTSH2(fyn) fusion protein (lanes 2-8) .
(Lanes 3-8) Afterprecipitationwith GSTSH2(fyn), com-
plexes were dissociated by boiling for 5 min in3% SDS
and equal aliquots reprecipitated with rabbit anti-mouse
(lane 4), anti-p130 (lane 5), GST (lane 6), GSTSH2(fyn)
(lane 7), and antiphosphotyrosine (lane 8) . Lane 3 is a
control aliquot of the solubilized p120/130 before
reprecipitation . Samples were separated by SDS-PAGE,
transferred to nitrocellulose, and probed with antiphos-
photyrosine . (C) TCR-P/CD3 complex was cross-linked
with anti-CD3 (+ samples) for 10 min and the cells
solubilized in 1% NP-40 (Brij 96 for anti-CD3) lysis
buffer. After incubation of lysates (lanes 1 and 2) with
anti-CD3 (lanes 3 and 4), anti-fyn (lanes 5 and 6), anti-
p130 (lanes 7 and 8) or GSTSH2(fyn) (lanes 9 and 10),
the samples were separated by SDS-PAGE, transferred
onto nitrocellulose, and probed with antiphosphotyro-
sine Ab.coprecipitating p120/130 (Fig. 3 C, lanes 3 and 4). p59fyn
association with p120/130 in fibroblasts showed that the
p59fm-p120/130 association can occur independent of TCR-~/
CD3 receptor complex expression (14). Furthermore, p120/130
was found associated with p59fyn(T) from cell lysates depleted
by anti-CD3 Ab (data not shown). Preassembly of a portion
of p59frn(T)-p120/130 in a complex, before its association
with the TCR-t/CD3 complex is therefore likely to occur.
Whether the NH2-terminal binding to TCR-t/CD3 further
influences the ability of the fyn-SH2 to bind p120/130 is
unclear.
The fyn-SH2:p120/130 interaction may serve as a model
in understanding mechanisms by which receptor-associated
src-related kinases use SH2 domains in the recruitment of
downstream signaling molecules. Limited SH2 mediated
binding to PI 3-kinase has also been noted; however, it occurs
only subsequent to TCR-~/CD3 ligation (32) . By contrast,
p120/130 binding to fyn-SH2 was detected both before and
after receptor ligation. The mechanism of receptor-substrate
binding is clearly different from that used by receptor tyro-
sine kinases such as the PDGF-R. Whereas binding to both
types of receptor is regulated by tyrosine phosphorylation,
the association with receptor tyrosine kinases such as the
PDGF-R is regulated by autophosphorylation between ho-
mologous receptors. Distinct autophosphorylation sites serve
to bind SH2 domains ofmultiple molecules such as the PI-3
kinase, rasGAP, PLCy, NCK, SHC, and p59fyn itself (22,
23, 36). By contrast, in the case of TCR-~/CD3-p59fyn(T),
the receptor-associated src kinase complex defines the specificity
of binding by virtue of its own SH2 domain. Thus, since
a givenfyn-SH2 domain can bind only a single phosphotyro-
sine carrying polypeptide at a time, the nature of the SH2-
mediated intracellular signal from a given TCR-~/CD3-
p59fyn(T) receptor is likely to be more restricted and specific.
The structure and function of p120/130 remain to be de-
termined. Proteins within a similar molecular weight range
have been found to associate with activated forms of other
src kinases (37), and with the EGF-R via a transforming iso-
form of v-crk (38). V-crk is a SH2 carrying adaptor protein
derived from CT10 avian sarcoma virus. Both v-crk and its
NH2-terminal SH2 domain bind to a denatured fibroblast
protein at 130 kD (38). Reprecipitation analysis (Fig. 3) in-
dicated that p120/130 corresponds to a 130-kD substrate of
transforming form of pp60°-SI° in v-src transfected chicken
embryo fibroblasts (28). In other studies (39) the same authors
further revealed that SH2 deletion mutants of v-src failed to
bind to p130. Our studies show that the fyn-SH2 domain
alone is sufficient to mediate the interaction. Interestingly,
in nontransfected fibroblasts, p130 was primarily detected in
the nucleus, whereas transformation by v-src resulted in an
apparent translocation ofp130 to the plasma membrane (39).
We have further shown that p120/130 is coupled to a surface
receptor, and as such is likely to play a role in receptor medi-
ated signaling. Consistent with this, p120/130 undergoes rapid
tyrosine phosphorylation upon TCR-~/CD3 ligation (Figs.
1 and 3). The structure of the 130-kD polypeptide recog-
nized by this Ab has yet to be established. Antibodies to PLCy
and GTP'ase-activating protein have failed to precipitate the
p120/130 molecules (data not shown). The presence of fyn-
associated p120/130 in fibroblasts (14) suggests a signaling
function for this molecule that is common to mammalian
cells. Other studies have shown that in transfected NIH-3T3
fibroblasts expressing human muscarinic receptors, stimula-
tion with carbachol but not PDGF, leads to increased tyro-
sine phosphorylation of p130 and p125f'k (40), suggesting
that p120/130 may also be involved in a signaling from
G-protein coupled receptors. We are presently attempting to
determine the structure of p120/130.
Given the fact that several receptor-associated src-related
kinases (p56kk, p59fyn, p62ye5) are expressed in T cells, it will
be important to identify, the downstream targets that are
specifically linked to one kinase relative to another. In this
sense, it is interesting that p120/130 was found to be prefer-
entially associated with p59fyn(T), as detected by in vitro la-
beling (Fig. 1) . Whereas accepting the unlikely possibility
that p120/130 may be resistant to labeling by p56<<k, these
data argue that p120/130 preferentially associates with
p59fyn(T) in T cells. p120/130 may therefore serve as a marker
for signals derived specifically from p59fyn(T). The mechanism
for this preferential association is still unclear. Preliminary
data have shown that GST kk-SH2 fusion proteins are capable
of reacting with p120/130 (data not shown). Other regions
of the kinase such as the NH2-terminal region or SH3 do-
main may influence the ability of the SH2 domains to in-
teract with substrate. Indeed, we have recently demonstrated
that SH3 mediated binding to PI-3 kinase is altered by the
presence of an adjacent SH2 domain (32).
Current evidence suggests that TCR-~/CD3 complex is
a multimeric complex with the capacity to generate distinct
signals emanating from the TCR ~ chains and various CD3
chains (41, 42). Nevertheless, in both cases, receptor ligation
induced the tyrosine phosphorylation of a prominent 120-
kD protein. This is consistent with the report that p59fyn(T)
can associate with the TCR-~ and various CD3 chains (11),
and introduces the possibility that p120/130 may be used in
both pathways of activation. In addition, p59fyn(T> negative
transgenic mice showed a marked reduction in the phosphory-
lation of a 130-kD band in TCR-~/CD3 stimulated thymo-
cytes, providing further suggestive evidence for the involve-
ment of p120/130 in the fyn-generated signals (18).
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